Interventional Neurology Market Research Report Information By Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, & Others), Product (Aneurysm Coiling & Embolization, Neurothrombectomy, Support Devices, & Others), End User – Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Interventional Neurology Market, by Disease Pathology

6.1 Introduction

6.2 Cerebral Aneurysms

Market Estimates &Forecast, by Region, 2020-2027

Market Estimates &Forecast, by Country, 2020-2027

6.3 Arteriovenous Malformation and Fistulas

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Ischemic Strokes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Interventional Neurology Market, by Product

7.1 Introduction

7.2 Aneurysm Coiling & Embolization Devices

7.2.1 Embolic Coils

7.2.1.1 Bare Detachable Coils

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.1.2 Coated Detachable Coils

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.2 Flow Diversion Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2.3 Liquid Embolic Agents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3 Cerebral Balloon Angioplasty and Stenting Systems

7.3.1 Carotid Artery Stents

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2 Embolic Protection Systems

7.3.2.1 Distal Filter Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3.2.2 Balloon Occlusion Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4 Neurothrombectomy Devices

7.4.1 Clot Retrieval Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.2 Suction and Aspiration Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4.3 Snares

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5 Support Devices

7.5.1 Microcatheters

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.5.2 Microguidewires

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Interventional Neurology Market, by End User

8.1 Introduction

8.2 Hospitals & Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.4 Research & Academic Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 9. Global Interventional Neurology Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 U.S.

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Medtronic PLC

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Johnson & Johnson

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Boston Scientific Corporation

11.4.1 Company Overview

11.4.2 Technologys/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Stryker Corporation

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Terumo Corporation

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Penumbra, Inc.

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Microport Scientific Corporation

11.8.1 Overview

11.8.2 Type/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Merit Medical Systems, Inc.

11.9.1 Overview

11.9.2 TypeOverview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 W.L. Gore & Associates, Inc.

11.10.1 Overview

11.10.2 TypeOverview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 B. Braun Melsungen AG

11.11.1 Overview

11.11.2 TypeOverview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Cook Medical

11.12.1 Overview

11.12.2 Type Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Other

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictionsfor the Global Interventional Neurology Market

Chapter 13. Appendix

LIST OF TABLES

Table 1 Interventional Neurology Market Synopsis, 2020-2027

Table 2 Interventional Neurology Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Interventional Neurology Market, by Region, 2020-2027 (USD Million)

Table 4 Global Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 5 Global Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 6 Global Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 7 North America: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 8 North America: Interventional Neurology Market, by Product, 2020-2027(USD Million)

Table 9 North America: Interventional Neurology Market, End User, 2020-2027 (USDMillion)

Table 10 US: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 11 US: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 12 US: Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 13 Canada:Interventional Neurology Market,byTechnique, 2020-2027 (USD Million)

Table 14 Canada: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 15 Canada: Interventional Neurology Market, End User, 2020-2027 (USDMillion)

Table 16 South America: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 17 South America: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 18 South America: Interventional Neurology Market, End User, 2020-2027 (USDMillion)

Table 19 Europe: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 20 Europe: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 21 Europe: Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 22 Western Europe: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USDMillion)

Table 23 Western Europe: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 24 Western Europe: Interventional Neurology Market, by End User, 2020-2027(USD Million)

Table 25 Eastern Europe: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 26 Eastern Europe: Interventional Neurology Market, by Product, 2020-2027 (USD Million)

Table 27 Eastern Europe: Interventional Neurology Market, End User, 2020-2027(USD Million)

Table 28 Asia-Pacific: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 29 Asia-Pacific: Interventional Neurology Market,by Product, 2020-2027 (USD Million)

Table 30 Asia-Pacific: Interventional Neurology Market, End User, 2020-2027 (USD Million)

Table 31 Middle East & Africa: Interventional Neurology Market, by Disease Pathology, 2020-2027 (USD Million)

Table 32 Middle East & Africa: Interventional Neurology Market, by Product,2020-2027 (USD Million)

Table 33 Middle East & Africa: Interventional Neurology Market, End User, 2020-2027(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Interventional Neurology Market

Figure 3 Market Dynamics for Global Interventional Neurology Market

Figure 4 Interventional Neurology Market Share, by Disease Pathology,2020

Figure 5 Interventional Neurology Market Share, by Product,2020

Figure 6 Interventional Neurology Market Share, End User, 2020

Figure 7 Interventional Neurology Market Share, by Region, 2020

Figure 8 North America: Interventional Neurology Market Share, by Country, 2020

Figure 9 Europe: Interventional Neurology Market Share, by Country, 2020

Figure 10 Asia-Pacific: Interventional Neurology Market Share, by Country, 2020

Figure 11 Middle East & Africa: Interventional Neurology Market Share, by Region, 2020

Figure 12 Interventional Neurology Market : Company Share Analysis, 2020 (%)

Figure 13 Abbott Laboratories: Key Financials

Figure 14 Abbott Laboratories: Segmental Revenue

Figure 15 Abbott Laboratories: Geographical Revenue

Figure 16 Medtronic PLC : Key Financials

Figure 17 Medtronic PLC : Segmental Revenue

Figure 18 Medtronic PLC : Geographical Revenue

Figure 19 Johnson & Johnson:Key Financials

Figure 20 Johnson & Johnson: Segmental Revenue

Figure 21 Johnson & Johnson: Geographical Revenue

Figure 22 Boston Scientific Corporation: Key Financials

Figure 23 Boston Scientific Corporation: Segmental Revenue

Figure 24 Boston Scientific Corporation: Geographical Revenue

Figure 25 Stryker Corporation:Key Financials

Figure 26 Stryker Corporation: Segmental Revenue

Figure 27 Stryker Corporation: Geographical Revenue

Figure 28 Terumo Corporation: Key Financials

Figure 29 Terumo Corporation: Segmental Revenue

Figure 30 Terumo Corporation: Geographical Revenue

Figure 31 Penumbra, Inc.: Key Financials

Figure 32 Penumbra, Inc.: Segmental Revenue

Figure 33 Penumbra, Inc.: Geographical Revenue

Figure 34 Microport Scientific Corporation:Key Financials

Figure 35 Microport Scientific Corporation: Segmental Revenue

Figure 36 Microport Scientific Corporation: Geographical Revenue

Figure 37 Merit Medical Systems, Inc.: Key Financials

Figure 38 Merit Medical Systems, Inc.: Segmental Revenue

Figure 39 Merit Medical Systems, Inc.: Geographical Revenue

Figure 40 W.L. Gore & Associates, Inc.: Key Financials

Figure 41 W.L. Gore & Associates, Inc.: Segmental Revenue

Figure 42 W.L. Gore & Associates, Inc.: Geographical Revenue

Figure 43 B. Braun Melsungen AG : Key Financials

Figure 44 B. Braun Melsungen AG :Segmental Revenue

Figure 45 B. Braun Melsungen AG : Geographical Revenue

Figure 46 Cook Medical: Key Financials

Figure 47 Cook Medical: Segmental Revenue

Figure 48 Cook Medical: Geographical Revenue